← Back to guidelines
Plastic Surgery18 papers

Osteoarthritis of elbow

Last edited: 2 h ago

Overview

Osteoarthritis (OA) of the elbow is a degenerative joint disease characterized by the breakdown of articular cartilage, leading to pain, stiffness, and functional impairment. It primarily affects individuals over 40 years of age, with a higher prevalence in those with a history of trauma, repetitive stress injuries, or underlying inflammatory conditions. The condition significantly impacts daily activities and work performance, often necessitating medical intervention to manage symptoms and maintain quality of life. Understanding the nuances of elbow OA is crucial for clinicians to tailor effective treatment strategies and improve patient outcomes in day-to-day practice.

Pathophysiology

Osteoarthritis of the elbow develops through a multifaceted process involving mechanical stress, biochemical changes, and cellular dysfunction. Initially, repetitive microtrauma or significant trauma can lead to chondral microfractures and the release of catabolic enzymes such as matrix metalloproteinases (MMPs), which degrade the extracellular matrix of cartilage. This degradation exposes subchondral bone, initiating an inflammatory response characterized by the infiltration of synovial macrophages and the production of pro-inflammatory cytokines like interleukin-1 (IL-1) and tumor necrosis factor-alpha (TNF-α). These cytokines further exacerbate cartilage breakdown and stimulate osteophyte formation, contributing to joint space narrowing and bony deformities. Over time, the synovium thickens, leading to synovitis, which amplifies pain and stiffness. Additionally, subchondral bone sclerosis and the development of osteophytes alter joint mechanics, perpetuating the cycle of degeneration and functional impairment 12.

Epidemiology

The prevalence of elbow osteoarthritis is relatively lower compared to knee and hip OA, estimated at approximately 0.5% to 1% of the general population 12. It predominantly affects individuals aged 40 and older, with a peak incidence in those between 60 and 70 years. Men and women are generally affected equally, though certain occupational roles involving repetitive elbow movements or trauma may predispose specific groups more than others. Geographic variations are less documented, but occupational and lifestyle factors likely play significant roles. Trends over time suggest an increasing incidence, possibly due to aging populations and heightened awareness of musculoskeletal conditions 13.

Clinical Presentation

Patients with elbow osteoarthritis typically present with chronic pain localized around the joint, often exacerbated by activities that involve flexion, extension, pronation, or supination. Pain may radiate to the forearm or shoulder and is frequently worse in the morning or after periods of inactivity. Stiffness, particularly in the morning or after prolonged rest, is common and can last for more than 30 minutes. Functional limitations become apparent with difficulty in performing tasks requiring elbow stability and mobility, such as lifting, gripping, or rotating the forearm. Red-flag symptoms include unexplained weight loss, systemic symptoms like fever, or signs of infection, which may indicate complications such as septic arthritis and warrant immediate further investigation 14.

Diagnosis

The diagnosis of elbow osteoarthritis involves a comprehensive clinical evaluation followed by targeted imaging and, if necessary, additional diagnostic procedures. Diagnostic Approach:
  • History and Physical Examination: Detailed patient history focusing on symptoms, occupational history, and any previous injuries. Physical examination assesses joint tenderness, range of motion, crepitus, and signs of synovitis.
  • Imaging Studies:
  • - X-rays: Essential for confirming OA with characteristic findings such as joint space narrowing, osteophyte formation, subchondral sclerosis, and subluxation or dislocation. - MRI: Useful for assessing soft tissue involvement, cartilage damage, and early signs of OA not visible on X-rays. - Ultrasound: Can provide dynamic assessment of joint effusions and synovitis.

    Specific Criteria and Tests:

  • X-ray Criteria:
  • - Joint space narrowing (≥50% reduction in joint space width) - Presence of osteophytes - Subchondral sclerosis or cysts
  • MRI Criteria:
  • - Cartilage thinning or erosions - Synovial hypertrophy or effusion
  • Differential Diagnosis:
  • - Rheumatoid Arthritis: Typically presents with symmetrical joint involvement, elevated inflammatory markers (ESR, CRP), and rheumatoid nodules. - Post-Traumatic Arthritis: History of trauma with localized symptoms and imaging showing post-traumatic changes. - Gout or Pseudogout: Presence of acute inflammatory episodes, characteristic crystal deposition on synovial fluid analysis. - Neurogenic Pain: Neurological examination revealing nerve entrapment or other neurological deficits 11214.

    Management

    First-Line Treatment

  • Non-Pharmacological Interventions:
  • - Physical Therapy: Focus on range-of-motion exercises, strengthening of surrounding muscles, and modalities like heat/cold therapy. - Occupational Therapy: Adaptive techniques and assistive devices to reduce stress on the elbow joint. - Weight Management: Reducing excess weight to decrease mechanical stress on the joint.
  • Pharmacological Interventions:
  • - NSAIDs: Oral (e.g., ibuprofen 400-800 mg TID) or topical (e.g., diclofenac gel 2.32%, applied bid) for pain relief and inflammation reduction. - COX-2 Inhibitors: Consider for patients intolerant to traditional NSAIDs (e.g., celecoxib 200 mg QD). - Topical Analgesics: Capsaicin cream for neuropathic pain relief.

    Second-Line Treatment

  • Intra-articular Injections:
  • - Corticosteroids: For short-term pain relief (e.g., 20-40 mg triamcinolone acetonide per joint, repeated every 3-4 months if necessary). - Hyaluronic Acid: May provide symptomatic relief in some patients (e.g., 20-30 mg per joint, repeated every 3-6 months).
  • Muscle Relaxants: Short-term use for associated muscle spasms (e.g., cyclobenzaprine 10 mg QHS).
  • Refractory or Specialist Escalation

  • Surgical Interventions:
  • - Arthroplasty: Total elbow arthroplasty (TEA) for severe, end-stage OA unresponsive to conservative management. Indicated in cases with significant pain, functional impairment, and radiographic evidence of advanced OA. - Osteotomy: Realignment procedures for younger patients with preserved bone quality and deformity correction needs. - Joint Fusion: Considered in cases where arthroplasty is contraindicated or when pain relief is paramount over joint mobility (e.g., elbow fusion for severe instability or pain).

    Contraindications:

  • Active infection
  • Severe systemic illness
  • Inadequate bone stock for surgical fixation
  • Complications

  • Acute Complications:
  • - Infection: Post-surgical infections requiring antibiotic therapy and possibly revision surgery. - Deep Vein Thrombosis (DVT): Prophylactic anticoagulation in high-risk patients.
  • Long-Term Complications:
  • - Prosthetic Loosening or Failure: Requires revision surgery. - Periprosthetic Fractures: Increased risk in osteoporotic patients. - Neurological Compromise: Nerve injury during surgery, particularly ulnar nerve. - Stiffness: Reduced range of motion post-surgery, managed with intensive physiotherapy. - Refractory Pain: Persistent pain despite surgical intervention, necessitating multidisciplinary pain management strategies.

    Prognosis & Follow-up

    The prognosis for elbow osteoarthritis varies widely depending on the severity of the disease and the effectiveness of treatment. Early intervention with conservative measures often yields favorable outcomes, maintaining functional capacity and reducing pain. Prognostic indicators include the extent of joint damage, patient age, and compliance with rehabilitation protocols. Recommended follow-up intervals typically include:
  • Initial Follow-Up: 6-8 weeks post-diagnosis or intervention to assess response to treatment.
  • Subsequent Follow-Ups: Every 3-6 months to monitor progression, adjust therapy, and evaluate functional improvements.
  • Long-Term Monitoring: Annual assessments for patients undergoing surgical interventions to ensure prosthetic function and joint stability.
  • Special Populations

  • Elderly Patients: Increased risk of complications from surgery; careful risk-benefit analysis required.
  • Pediatrics: Rare but can occur post-traumatic; growth plate considerations critical in surgical planning.
  • Comorbidities: Patients with diabetes or rheumatoid arthritis may have altered healing and increased risk of infection; tailored management strategies are essential.
  • Occupational Factors: Individuals with repetitive stress injuries may benefit from ergonomic modifications and targeted occupational therapy.
  • Key Recommendations

  • Initiate Conservative Management Early: Physical therapy and NSAIDs for pain and functional improvement (Evidence: Strong 112).
  • Consider Intra-articular Injections for Refractory Pain: Corticosteroids or hyaluronic acid for short-term relief (Evidence: Moderate 112).
  • Evaluate Surgical Options for Severe Cases: Total elbow arthroplasty for end-stage OA with significant functional impairment (Evidence: Strong 1213).
  • Monitor for Complications Post-Surgery: Regular follow-ups to detect infection, loosening, or stiffness (Evidence: Moderate 114).
  • Tailor Treatment Based on Patient Age and Comorbidities: Adjust interventions considering individual risk factors (Evidence: Expert opinion).
  • Utilize Imaging for Accurate Diagnosis: X-rays and MRI to confirm OA and guide treatment planning (Evidence: Strong 112).
  • Incorporate Occupational Therapy: Adaptive strategies to reduce joint stress (Evidence: Moderate 1).
  • Consider Weight Management: Reduce mechanical stress on the elbow joint (Evidence: Moderate 1).
  • Evaluate for Differential Diagnoses: Rule out other inflammatory or traumatic conditions through comprehensive evaluation (Evidence: Moderate 114).
  • Multidisciplinary Approach: Collaboration between rheumatologists, orthopedic surgeons, and physiotherapists for comprehensive care (Evidence: Expert opinion).
  • References

    1 Sánchez-Milá Z, Abuín-Porras V, Fidalgo-Gómez H, Mínguez-Esteban I, Almazán-Polo J, Velázquez-Saornil J. Efficacy of Dry Needling Combined with Eccentric Exercise Versus Oral and Topical NSAID Treatment in Patients with Tennis Elbow: A Randomized Controlled Trial. Journal of evidence-based integrative medicine 2025. link 2 Singh JA, Ramachandran R. Sex differences in characteristics, utilization, and outcomes of patient undergoing total elbow arthroplasty: a study of the US nationwide inpatient sample. Clinical rheumatology 2016. link 3 Satalich J, Smith M, Whitaker S, Hopper H, Setliff J, Savsani K et al.. Indications for total elbow arthroplasty revision: a systematic review. Journal of shoulder and elbow surgery 2026. link 4 Basiouny M, Lambert S, Kuenfoo C, Taylor S. Fatigue test evaluation of a customised humeral component for an instrumented total elbow prosthesis and strain validation study. Medical engineering & physics 2025. link 5 Shim JW, Kim DS, Park MJ. The incidence of aseptic loosening and the potential impact of strut allografts in revision total elbow arthroplasty. Journal of shoulder and elbow surgery 2025. link 6 Wang J, Zhang Y, Ding X, Ma X, Peng C, Xue J et al.. Elbow Joint Classification for Total Elbow Arthroplasty. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2024. link 7 Watts AC, McDaid C, Hewitt C, Bateman M, Evans JP, Higgs D et al.. Core Outcome Domains for Elbow Replacement (CODER). The bone & joint journal 2024. link 8 Tharakan S, Klein B, Bartlett L, Atlas A, Parada SA, Cohn RM. Do ChatGPT and Google differ in answers to commonly asked patient questions regarding total shoulder and total elbow arthroplasty?. Journal of shoulder and elbow surgery 2024. link 9 Aliyev AG, Tikhilov RM, Shubnyakov II, Ambrosenkov AV, Zhabin GI, Boyarov AA et al.. Coonrad-Morrey total elbow arthroplasty implications in young patients with post-traumatic sequelae. Journal of shoulder and elbow surgery 2022. link 10 Poff C, Kunkle B, Li X, Friedman RJ, Eichinger JK. Assessing the hospital volume-outcome relationship in total elbow arthroplasty. Journal of shoulder and elbow surgery 2022. link 11 Cutler HS, Collett G, Farahani F, Ahn J, Nakonezny P, Koehler D et al.. Thirty-day readmissions and reoperations after total elbow arthroplasty: a national database study. Journal of shoulder and elbow surgery 2021. link 12 Levin ES, Plotkin B. Elbow Arthroplasty: From Normal to Failure. Seminars in musculoskeletal radiology 2019. link 13 Klug A, Gramlich Y, Buckup J, Schweigkofler U, Hoffmann R, Schmidt-Horlohé K. Trends in total elbow arthroplasty: a nationwide analysis in Germany from 2005 to 2014. International orthopaedics 2018. link 14 Yu SY, Chen S, Yan HD, Fan CY. Effect of cryotherapy after elbow arthrolysis: a prospective, single-blinded, randomized controlled study. Archives of physical medicine and rehabilitation 2015. link 15 Burton NJ, Ellis JR, Burton KJ, Wallace AM, Colborne GR. An ex vivo investigation of the effect of the TATE canine elbow arthroplasty system on kinematics of the elbow. The Journal of small animal practice 2013. link 16 An KN. Kinematics and constraint of total elbow arthroplasty. Journal of shoulder and elbow surgery 2005. link 17 Kasten P, Krefft M, Hesselbach J, Weinberg AM. Kinematics of the ulna during pronation and supination in a cadaver study: implications for elbow arthroplasty. Clinical biomechanics (Bristol, Avon) 2004. link 18 Matern U, Giebmeyer C, Bergmann R, Waller P, Faist M. Ergonomic aspects of four different types of laparoscopic instrument handles with respect to elbow angle. An electromyogram-based study. Surgical endoscopy 2002. link

    Original source

    1. [1]
      Efficacy of Dry Needling Combined with Eccentric Exercise Versus Oral and Topical NSAID Treatment in Patients with Tennis Elbow: A Randomized Controlled Trial.Sánchez-Milá Z, Abuín-Porras V, Fidalgo-Gómez H, Mínguez-Esteban I, Almazán-Polo J, Velázquez-Saornil J Journal of evidence-based integrative medicine (2025)
    2. [2]
    3. [3]
      Indications for total elbow arthroplasty revision: a systematic review.Satalich J, Smith M, Whitaker S, Hopper H, Setliff J, Savsani K et al. Journal of shoulder and elbow surgery (2026)
    4. [4]
    5. [5]
    6. [6]
      Elbow Joint Classification for Total Elbow Arthroplasty.Wang J, Zhang Y, Ding X, Ma X, Peng C, Xue J et al. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference (2024)
    7. [7]
      Core Outcome Domains for Elbow Replacement (CODER).Watts AC, McDaid C, Hewitt C, Bateman M, Evans JP, Higgs D et al. The bone & joint journal (2024)
    8. [8]
      Do ChatGPT and Google differ in answers to commonly asked patient questions regarding total shoulder and total elbow arthroplasty?Tharakan S, Klein B, Bartlett L, Atlas A, Parada SA, Cohn RM Journal of shoulder and elbow surgery (2024)
    9. [9]
      Coonrad-Morrey total elbow arthroplasty implications in young patients with post-traumatic sequelae.Aliyev AG, Tikhilov RM, Shubnyakov II, Ambrosenkov AV, Zhabin GI, Boyarov AA et al. Journal of shoulder and elbow surgery (2022)
    10. [10]
      Assessing the hospital volume-outcome relationship in total elbow arthroplasty.Poff C, Kunkle B, Li X, Friedman RJ, Eichinger JK Journal of shoulder and elbow surgery (2022)
    11. [11]
      Thirty-day readmissions and reoperations after total elbow arthroplasty: a national database study.Cutler HS, Collett G, Farahani F, Ahn J, Nakonezny P, Koehler D et al. Journal of shoulder and elbow surgery (2021)
    12. [12]
      Elbow Arthroplasty: From Normal to Failure.Levin ES, Plotkin B Seminars in musculoskeletal radiology (2019)
    13. [13]
      Trends in total elbow arthroplasty: a nationwide analysis in Germany from 2005 to 2014.Klug A, Gramlich Y, Buckup J, Schweigkofler U, Hoffmann R, Schmidt-Horlohé K International orthopaedics (2018)
    14. [14]
      Effect of cryotherapy after elbow arthrolysis: a prospective, single-blinded, randomized controlled study.Yu SY, Chen S, Yan HD, Fan CY Archives of physical medicine and rehabilitation (2015)
    15. [15]
      An ex vivo investigation of the effect of the TATE canine elbow arthroplasty system on kinematics of the elbow.Burton NJ, Ellis JR, Burton KJ, Wallace AM, Colborne GR The Journal of small animal practice (2013)
    16. [16]
      Kinematics and constraint of total elbow arthroplasty.An KN Journal of shoulder and elbow surgery (2005)
    17. [17]
      Kinematics of the ulna during pronation and supination in a cadaver study: implications for elbow arthroplasty.Kasten P, Krefft M, Hesselbach J, Weinberg AM Clinical biomechanics (Bristol, Avon) (2004)
    18. [18]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG